With a strong clinical-phase pipeline, Agenus harnesses a mix of proprietary antibody platforms, like Retrocyte Show™ and SECANT®, and progressive cell therapy approaches, positioning alone to be a critical contributor from the biotechnology and immunotherapy arena.These integrated systems let for the development of both of those solitary-agent